Interestingly, we found that enhanced levels of certain tumor markers, specifically CA199 and ProGRP, could be potentially used as simple and practical clinical predictors of EGFR 19del and T790M mutation detection by dPCR liquid biopsy assay. The gene discussed is EGFR; the disease is neoplasm.